We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Application of 16 G Biopsy Needle in Transperineal Template-Guided Prostate Biopsy.
- Authors
Ding, Xue-fei; Luan, Yang; Xia, An-le; Zhu, Liang-yong; Xiao, Qin; Chen, Ji; Chen, Hao-peng; Han, Yue-xing; Liu, Zhong
- Abstract
Background: The aim of this study was to evaluate the clinical value of 16 G biopsy needle in transperineal template-guided prostate biopsy (TTPB), compared with 18 G biopsy needle. Methods: The patients who underwent TTPB from August 2020 to February 2021 were randomized into 2 groups using a random number table. The control group (n = 65) and the observation group (n = 58) performed biopsy with 18 G (Bard MC l820) and 16 G (Bard MC l616) biopsy needles, respectively. Positive rate of biopsy, Gleason score, complications, and pain score were statistically analyzed. Results: The age, prostate volume, PSA, and the number of cores were comparable between the 2 groups. The positive rate of biopsy in the observation group was 68.9% (40/58), meanwhile the control group was 46.2% (30/65). There was statistical difference between the 2 groups (p = 0.011). Gleason score of the observation group (8 [7–9]) was higher than that of the control group (8 [6–9]) (p = 0.038). There was no significant difference in pain score and complications including hematuria, hematospermia, perineal hematoma, infection, and urinary retention between the 2 groups (p > 0.05). Conclusions: 16 G biopsy needle significantly improved the positive rates and accurately evaluate the nature of lesions, meanwhile did not increase the incidence of complications compared with 18 G biopsy needle.
- Subjects
NEEDLE biopsy; PROSTATE biopsy; GLEASON grading system; NEEDLES &; pins; RANDOM numbers; RETENTION of urine; NEEDLESTICK injuries; CONTROL groups
- Publication
Urologia Internationalis, 2022, Vol 106, Issue 9, p909
- ISSN
0042-1138
- Publication type
Article
- DOI
10.1159/000520373